Bone metastases from renal cell carcinoma: 4 years after aggressive
surgeries and anti-angiogenic therapy
Abstract
Management of bone metastases from renal cell carcinoma (RCC) has
significantly changed after the era of targeted therapy that improved
the overall survival (OS).Surgical decision-making remains a subject of
controversy.We report a case of pelvic bone metastasis from RCC, 2
months after nephrectomy and surgery of a revealing clavicular
metastasis